By
Brenton Flynn
|
More Articles
November 9, 2012
|
When a company has generated a lot of excitement -- like MAKO Surgical (Nasdaq: MAKO ) has with its disruptive product and interesting growth story -- and then takes a big hit in share price, it's worth a closer look to see what's going on. In this video, Motley Fool health care bureau chief Brenton Flynn takes a more in-depth look at the company and gives you some reasons you should consider being bullish on MAKO -- and some reasons not to be.
The recent market sell-off of MAKO Surgical shares has many wondering whether the potential growth prospects of the robotic surgery company make this stock a buy or a stock to stay away from. To answer this question, Fool.com analyst and MAKO expert David Meier has authored a premium research report covering all of the must-know details on the company, including key areas to watch and risks looming in the future. As an added bonus, David will keep you informed with a full year of updates and guidance on MAKO Surgical as news breaks. Click here now to learn more and start reading.